JP2014094965A5 - - Google Patents

Download PDF

Info

Publication number
JP2014094965A5
JP2014094965A5 JP2014016565A JP2014016565A JP2014094965A5 JP 2014094965 A5 JP2014094965 A5 JP 2014094965A5 JP 2014016565 A JP2014016565 A JP 2014016565A JP 2014016565 A JP2014016565 A JP 2014016565A JP 2014094965 A5 JP2014094965 A5 JP 2014094965A5
Authority
JP
Japan
Prior art keywords
solvent
active ingredient
solute
ultrasonic
liquid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014016565A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014094965A (ja
JP5808830B2 (ja
Filing date
Publication date
Priority claimed from GBGB0705159.2A external-priority patent/GB0705159D0/en
Application filed filed Critical
Publication of JP2014094965A publication Critical patent/JP2014094965A/ja
Publication of JP2014094965A5 publication Critical patent/JP2014094965A5/ja
Application granted granted Critical
Publication of JP5808830B2 publication Critical patent/JP5808830B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2014016565A 2007-03-19 2014-01-31 結晶の製造方法 Active JP5808830B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0705159.2 2007-03-19
GBGB0705159.2A GB0705159D0 (en) 2007-03-19 2007-03-19 Process for making crystals

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2009554087A Division JP2010522154A (ja) 2007-03-19 2008-03-18 結晶の製造方法

Publications (3)

Publication Number Publication Date
JP2014094965A JP2014094965A (ja) 2014-05-22
JP2014094965A5 true JP2014094965A5 (enExample) 2014-12-04
JP5808830B2 JP5808830B2 (ja) 2015-11-10

Family

ID=38008612

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2009554087A Pending JP2010522154A (ja) 2007-03-19 2008-03-18 結晶の製造方法
JP2014016565A Active JP5808830B2 (ja) 2007-03-19 2014-01-31 結晶の製造方法

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2009554087A Pending JP2010522154A (ja) 2007-03-19 2008-03-18 結晶の製造方法

Country Status (11)

Country Link
US (2) US9162160B2 (enExample)
EP (1) EP2134457B1 (enExample)
JP (2) JP2010522154A (enExample)
CN (1) CN101636223B (enExample)
BR (1) BRPI0809275A2 (enExample)
CA (1) CA2680105C (enExample)
ES (1) ES2701728T3 (enExample)
GB (2) GB0705159D0 (enExample)
IL (1) IL200802A (enExample)
RU (1) RU2456066C2 (enExample)
WO (1) WO2008114052A1 (enExample)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0705159D0 (en) * 2007-03-19 2007-04-25 Prosonix Ltd Process for making crystals
CN102149437B (zh) 2008-07-18 2017-02-15 普罗索尼克斯有限公司 用于提高氟替卡松颗粒结晶度的方法
GB0900080D0 (en) * 2009-01-06 2009-02-11 Prosonix Ltd An apparatus and process for producing crystals
GB0918431D0 (en) 2009-10-21 2009-12-09 Prosonix Ltd Process for improving crystallinity
EP2360147A1 (en) 2010-02-22 2011-08-24 CHIESI FARMACEUTICI S.p.A. Process for preparing crystalline particles of a salt of 8-hydroxy-5-[(1R)-1-hydroxy-2-[[(1R)-2-(4-methoxyphenyl)-1-methylethyl]amino] ethyl]-2(1H)-quinolinone (carmoterol)
RU2585101C2 (ru) 2010-04-01 2016-05-27 КЬЕЗИ ФАРМАЧЕУТИЧИ С.п.А. Способ приготовления частиц носителя для сухих порошков для ингаляции
EP2658811B1 (en) 2010-12-30 2019-06-12 Yava Technologies Inc. Method of production for transition metal compound particles
EP2500072A1 (en) 2011-03-15 2012-09-19 LEK Pharmaceuticals d.d. A novel process of residual solvent removal
GB201113662D0 (en) 2011-08-08 2011-09-21 Prosonix Ltd Pharmaceutical compositions
CN104093652B (zh) * 2011-11-28 2018-06-15 纳米产品公司 用于亚微米颗粒的阀和密封容器及相关方法
US8765725B2 (en) 2012-05-08 2014-07-01 Aciex Therapeutics, Inc. Preparations of hydrophobic therapeutic agents, methods of manufacture and use thereof
CN107880091B (zh) 2012-05-08 2020-12-18 尼科斯眼药公司 疏水性治疗剂的制剂、其制备方法及应用
CN102872612B (zh) * 2012-10-15 2013-11-27 中国工程物理研究院化工材料研究所 超声结晶器
US9815865B2 (en) 2013-01-07 2017-11-14 Nicox Ophthalmics, Inc. Preparations of hydrophobic therapeutic agents, methods of manufacture and use thereof
EA201591415A1 (ru) 2013-01-31 2016-01-29 Просоникс Лимитед Фармацевтические композиции, включающие многокомпонентные кристаллические частицы, подходящие для применения в ингаляционной терапии
GB201301721D0 (en) * 2013-01-31 2013-03-20 Prosonix Ltd Pharmaceutical Preparations
CN103172476A (zh) * 2013-04-08 2013-06-26 中国工程物理研究院化工材料研究所 一种亚微米颗粒1-氧-二氨基-3，5-二硝基吡嗪炸药的制备方法
US9469548B2 (en) * 2015-02-20 2016-10-18 Hydro Dynamics, Inc. Continuous hydrodynamic cavitation crystallization
CN105037253A (zh) * 2015-05-27 2015-11-11 上海应用技术学院 一种超声逼晶法提纯化合物的方法
CN105664816B (zh) * 2016-03-17 2017-11-03 杭州成功超声设备有限公司 将基于振幅控制的超声波设备用于化工装置的三步式方法
EP3369468A1 (en) * 2017-02-23 2018-09-05 Covaris, Inc. Acoustic energy-based control of particle count in crystallization
US10583085B2 (en) 2017-05-17 2020-03-10 Chiesi Farmaceutici S.P.A. Carrier particles for dry powder formulations for inhalation
PL3829641T3 (pl) 2018-07-27 2024-09-30 Chiesi Farmaceutici S.P.A. Nowe cząstki nośnikowe do preparatów suchego proszku do inhalacji
CN110330335A (zh) * 2019-07-19 2019-10-15 中国工程物理研究院化工材料研究所 铋基卤化物陶瓷材料、制备方法及x射线探测器
WO2021012044A1 (en) 2019-07-22 2021-01-28 Canopy Growth Corporation Continuous crystallization of cannabinoids in a stirred-tank reactor
CN110773079B (zh) * 2019-11-18 2022-03-01 江苏博迁新材料股份有限公司 一种超声喷雾法制备超细粉球的方法
CN112972384B (zh) * 2019-12-02 2022-03-18 长风药业股份有限公司 一种格隆溴铵和茚达特罗原料药微粉混合物的制备方法
GB2599890A (en) 2020-08-18 2022-04-20 Ashe Robert Improved loop reactor
CN114307840B (zh) * 2022-01-08 2022-09-16 安徽省农业科学院棉花研究所 一种有机配方肥热返料设备
CN115634635B (zh) * 2022-10-20 2025-03-18 江苏瑞祥化工有限公司 一种高纯度粒状2,5-二氯苯胺的制备装置及制备方法

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2033254C1 (ru) * 1988-02-23 1995-04-20 Александр Петрович Пляскин Способ обработки материалов и устройство для его осуществления
GB9310030D0 (en) * 1993-05-15 1993-06-30 Scras Dry processed particles and process for the preparation of the same
US5874029A (en) * 1996-10-09 1999-02-23 The University Of Kansas Methods for particle micronization and nanonization by recrystallization from organic solutions sprayed into a compressed antisolvent
EP1011856B1 (en) * 1997-08-05 2003-04-09 Microfluidics International Corporation Multiple stream high pressure mixer/reactor
US6465015B1 (en) * 1998-02-24 2002-10-15 Arch Chemicals, Inc. Sonic method of enhancing chemical reactions to provide uniform, non-agglomerated particles
GB9828721D0 (en) * 1998-12-24 1999-02-17 Glaxo Group Ltd Novel apparatus and process
TR200101891T2 (tr) * 1999-01-29 2001-12-21 Bristol-Myers Squibb Company Sonik etkili jet kristalleşme aparat ve cihazı.
GB9919693D0 (en) * 1999-08-19 1999-10-20 Rhone Poulenc Rorer Ltd Process
GB9925934D0 (en) 1999-11-03 1999-12-29 Glaxo Group Ltd Novel apparatus and process
US6620351B2 (en) * 2000-05-24 2003-09-16 Auburn University Method of forming nanoparticles and microparticles of controllable size using supercritical fluids with enhanced mass transfer
GB0015981D0 (en) * 2000-06-29 2000-08-23 Glaxo Group Ltd Novel process for preparing crystalline particles
GB0016040D0 (en) * 2000-06-29 2000-08-23 Glaxo Group Ltd Novel process for preparing crystalline particles
GB0016002D0 (en) * 2000-06-29 2000-08-23 Glaxo Group Ltd Novel process for preparing crystalline particles
US20040256749A1 (en) * 2000-12-22 2004-12-23 Mahesh Chaubal Process for production of essentially solvent-free small particles
CN1250312C (zh) * 2001-05-05 2006-04-12 阿山特斯有限公司 小晶体形成
US20030049323A1 (en) * 2001-08-29 2003-03-13 Hitt James E. Process to precipitate drug particles
GB0125604D0 (en) * 2001-10-25 2001-12-19 Glaxo Group Ltd Novel process
GB0201400D0 (en) * 2002-01-22 2002-03-13 Glaxo Group Ltd Novel apparatus and process
GB0219815D0 (en) 2002-08-24 2002-10-02 Accentus Plc Preparation of small crystals
US20040197275A1 (en) * 2002-10-17 2004-10-07 Ecole Polytechnique Federale De Lausanne Process for the manufacture of powders of inhalable medicaments
GB0300339D0 (en) * 2003-01-08 2003-02-05 Bradford Particle Design Ltd Particle formation
WO2004073827A1 (en) * 2003-02-21 2004-09-02 The University Of Bath Process for the production of particles
US7041144B2 (en) * 2003-03-04 2006-05-09 Five Star Technologies, Inc. Hydrodynamic cavitation crystallization process
US20080194868A1 (en) * 2003-03-04 2008-08-14 Kozyuk Oleg V Hydrodynamic cavitation crystallization device and process
JP2004276334A (ja) 2003-03-13 2004-10-07 Ricoh Co Ltd 感熱記録材料
JP5207432B2 (ja) * 2003-04-29 2013-06-12 エム・エス・ディー・オス・ベー・フェー アンチ溶媒凝固プロセス
US20060150892A1 (en) * 2003-04-29 2006-07-13 Akzo Nobel N.V. Processes Involving the Use of Antisolvent Crystallisation
GB0319797D0 (en) * 2003-08-26 2003-09-24 Leuven K U Res & Dev Particle size reduction of poorly soluble drugs
WO2005042219A1 (en) * 2003-10-24 2005-05-12 Ferro Corporation Method of forming particles
WO2005051511A1 (ja) 2003-11-28 2005-06-09 Mitsubishi Chemical Corporation 有機化合物微粒子の製造方法
JP2005177746A (ja) * 2003-11-28 2005-07-07 Mitsubishi Chemicals Corp 有機化合物微粒子の製造方法
GB0507165D0 (en) * 2005-04-08 2005-05-18 Glaxo Group Ltd Novel crystalline pharmaceutical product
US20090087492A1 (en) * 2006-03-14 2009-04-02 Merck & Co., Inc. Processes and Apparatuses for the Production of Crystalline Organic Microparticle Compositions by Micro-Milling and Crystallization on Micro-Seed and Their Use
US20080075777A1 (en) * 2006-07-31 2008-03-27 Kennedy Michael T Apparatus and methods for preparing solid particles
GB0705159D0 (en) * 2007-03-19 2007-04-25 Prosonix Ltd Process for making crystals
GB0711680D0 (en) * 2007-06-18 2007-07-25 Prosonix Ltd Process
EP2360147A1 (en) * 2010-02-22 2011-08-24 CHIESI FARMACEUTICI S.p.A. Process for preparing crystalline particles of a salt of 8-hydroxy-5-[(1R)-1-hydroxy-2-[[(1R)-2-(4-methoxyphenyl)-1-methylethyl]amino] ethyl]-2(1H)-quinolinone (carmoterol)

Similar Documents

Publication Publication Date Title
RU2009138325A (ru) Способ получения кристаллов
Li et al. Progress of the synthesis of condensed pyrazole derivatives (from 2010 to mid-2013)
JP2016512537A5 (enExample)
AR124481A2 (es) Método para producir cristales de alulosa, y los cristales de alulosa y el licor madre obtenidos por dicho método
NZ748618A (en) Infusion system with concurrent tpn/insulin infusion
MX372561B (es) Metodo para preparacion continua de cristales de metionina de alta densidad aparente.
JP2016511287A5 (enExample)
JP2017526747A5 (enExample)
RU2017133243A (ru) Частицы n-(5-циано-4-((2-метоксиэтил)амино)пиридин-2-ил)-7-формил-6-((4-метил-2-оксопиперазин-1-ил)метил)-3,4-дигидро-1,8-нафтиридин-1(2h)-карбоксамида
JP6949856B2 (ja) ５−アミノ−２，３−ジヒドロフタラジン−１，４−ジオンの結晶形の製造方法
JP2017512798A5 (enExample)
JP2016537346A5 (enExample)
HK1254645A1 (zh) 冻乾药物组合物
JP2014201743A5 (enExample)
JP2015189586A5 (enExample)
WO2014162308A3 (en) A method of preparing pure precious metal nanoparticles with large fraction of (100) facets, nanoparticles obtained by this method and their use
WO2016100949A3 (en) Method and compositions for dissolving or solubilizing therapeutic agents
CN106807100A (zh) 粒子的制造方法
PH12016502359B1 (en) Lobaplatin crystals, preparation methods and pharmaceutical applications
AR081267A1 (es) Procedimiento de obtencion de la forma cristalina a del febuxostat
EA201591418A1 (ru) Многокомпонентные кристаллические частицы для ингаляционной терапии
CN103772255B (zh) 一种低分子有机物/无机盐双水相萃取藻类中β-胡萝卜素的方法
CN110049968A (zh) 阿普斯特共晶及其制备方法
RU2017123264A (ru) Способ получения акриловой кислоты
RU2017100030A (ru) Способ производства фтороводорода